-Reuters
Guardant Health Q4 EPS $(1.17) Beats $(1.37) Estimate, Sales $126.89M Beat $124.08M Estimate
Guardant Health (NASDAQ:GH) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.37) by 14.6 percent. This is a 69.57 percent decrease over losses of $(0.69) per share from the